Clinical trials
Phase 1/2 Retinal Degeneration trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
| Recruiting | 5 |
| Completed | 4 |
| Terminated | 4 |
| Unknown status | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beacon Therapeutics | 2 |
| SparingVision | 2 |
| AsclepiX Therapeutics, Inc. | 1 |
| BlueRock Therapeutics | 1 |
| Catholic University of the Sacred Heart | 1 |
| Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 1 |
| Centro de Pesquisa Rubens Siqueira | 1 |
| David M. Brown, M.D. | 1 |
| Editas Medicine, Inc. | 1 |
| Elisigen, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinal Degeneration | 24 |
| Retinal Diseases | 13 |
| Eye Diseases | 10 |
| Retinitis Pigmentosa | 7 |
| Macular Degeneration | 6 |
| Retinal Dystrophies | 6 |
| Cone-Rod Dystrophies | 4 |
| Eye Diseases, Hereditary | 4 |
| Stargardt Disease | 3 |
| Choroidal Neovascularization | 2 |
Trials
Showing 51 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.